Document is current
Any future updates will be listed below
-
Authors
Sidiqi, M. Hasib
Aljama, Mohammed A.
Bin Riaz, Irbaz
Dispenzieri, Angela
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Buadi, Francis K.
Warsame, Rahma
Lacy, Martha Q.
Dingli, David
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Gonsalves, Wilson I.
Kapoor, Prashant
Kourelis, Taxiarchis V.
Hogan, William J. http://orcid.org/0000-0002-5841-4105
Rajkumar, S. Vincent http://orcid.org/0000-0002-5862-1833
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Gertz, Morie A.
- License Information
-
More Information
Article History
Received: 12 September 2018
Revised: 8 October 2018
Accepted: 24 October 2018
First Online: 8 November 2018
Conflict of interest
: M.A.G. received consultancy fromMillenium and honoraria from Celgene, Millenium, Onyx, Novartis, SmithKline, Prothena, Ionis, and Amgen. S.K.K. received consultancy from Celgene, Millennium, Onyx, Janssen, and BMS and research funding from Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS. M.Q.L. received research funding from Celgene. D.D. received research funding from Karyopharm Therapeutics, Amgen, and Millenium Pharmaceuticals. P.K. received research funding from Takeda, Celgene, and Amgen. A.D. received research funding from Celgene, Millennium, Pfizer, and Janssen and travel grant from Pfizer. The remaining authors declare that they have no conflict of interest..
: The study was approved by the Mayo Clinic institutional review board.
